Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science

Journal of Law, Medicine and Ethics 37 (4):685-687 (2009)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.1111/j.1748-720x.2009.00440.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,349

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
Commentary: Evaluating Oversight of Human Drugs and Medical Devices.Susan Bartlett Foote - 2009 - Journal of Law, Medicine and Ethics 37 (4):629-632.
Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences.Jordan Paradise, Susan M. Wolf, Jennifer Kuzma, Aliya Kuzhabekova, Alison W. Tisdale, Efrosini Kokkoli & Gurumurthy Ramachandran - 2009 - Journal of Law, Medicine and Ethics 37 (4):688-705.
What Does the History of Technology Regulation Teach Us about Nano Oversight?Gary E. Marchant, Douglas J. Sylvester & Kenneth W. Abbott - 2009 - Journal of Law, Medicine and Ethics 37 (4):724-731.
Dual-use research codes of conduct: Lessons from the life sciences. [REVIEW]Michael J. Selgelid - 2009 - NanoEthics 3 (3):175-183.
How Should Creationism and Intelligent Design be Dealt with in the Classroom?Michael J. Reiss - 2011 - Journal of Philosophy of Education 45 (3):399-415.
Review of the OSHA Framework for Oversight of Occupational Environments. [REVIEW]Jae-Young Choi & Gurumurthy Ramachandran - 2009 - Journal of Law, Medicine and Ethics 37 (4):633-650.
Evaluating Oversight Systems for Emerging Technologies: A Case Study of Genetically Engineered Organisms.Jennifer Kuzma, Pouya Najmaie & Joel Larson - 2009 - Journal of Law, Medicine and Ethics 37 (4):546-586.
Commentary: Is It Possible to Determine the Extent to Which Informational Asymmetries and Prejudice Bias Responses?Terrance Hurley - 2009 - Journal of Law, Medicine and Ethics 37 (4):594-597.
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology.Jordan Paradise, Alison W. Tisdale, Ralph F. Hall & Efrosini Kokkoli - 2009 - Journal of Law, Medicine and Ethics 37 (4):598-624.
Oversight ethics: The case of business licensing. [REVIEW]Asher Friedberg, Robert Schwartz & Shuki Amrani - 2004 - Journal of Business Ethics 53 (4):371-381.
Who's afraid of Deleuze and Guattari.Gregg Lambert - 2006 - New York, NY: Continuum.
Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization.Robbin Johnson - 2009 - Journal of Law, Medicine and Ethics 37 (4):587-593.
Word of Mouse.Jeremy Stangroom - 2005 - The Philosophers' Magazine 30:10-10.

Analytics

Added to PP
2016-02-04

Downloads
2 (#1,784,141)

6 months
1 (#1,510,037)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.

Add more references